RxDoctor Payments Data

Daniel Lynch, MD

Family Medicine · Libertyville, ILNPI 1477548782

Payments from drug & device makers

$26,666in general payments, 2019–2025

Across 1,026 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$5K
  • AstraZeneca$4K
  • AbbVie$3K
  • Amgen$2K
  • Boehringer Ingelheim$2K
  • Lilly USA, LLC$2K
  • plus $11K from 54 others

What the payments were for

  • Food & beverage$26,647100%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk145$4,633
AstraZeneca131$3,611
AbbVie(2 entities)135$2,516
Amgen37$1,930
Boehringer Ingelheim34$1,774
Lilly USA, LLC82$1,617
Pfizer62$1,522
Merck58$1,012
Sanofi-aventis U.S. LLC22$956
GSK28$585
Takeda Pharmaceuticals U.S.A., Inc.27$575
Corcept Therapeutics11$510
Amarin Pharma, Inc.25$479
Johnson & Johnson(2 entities)18$472
E.r. Squibb & Sons, L.L.C.8$430
Novartis20$351
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$295
Boston Scientific5$279
Philips North America LLC11$270
Biohaven Pharmaceuticals, Inc.12$246
Exact Sciences11$209
Sanofi Pasteur Inc.9$204
Azurity Pharmaceuticals, Inc.11$196
Abbott4$193
Jazz Pharmaceuticals Inc.9$170
Ardelyx, Inc.6$126
Idorsia Pharmaceuticals US Inc6$108
Esperion Therapeutics, Inc.5$84
Seqirus USA Inc5$82
Phadia US Inc.5$81
Paratek Pharmaceuticals, Inc.4$81
Arbor Pharmaceuticals, Inc.6$78
Bayer4$78
Phathom Pharmaceuticals, Inc.3$72
Teva Pharmaceuticals USA, Inc.5$70
Daiichi Sankyo Inc.3$64
Kowa Pharmaceuticals America, Inc.3$50
Ironwood Pharmaceuticals, Inc3$50
Avanir Pharmaceuticals, Inc.3$46
Neos Therapeutics, LP2$42
Shire North American Group Inc3$41
Harmony Biosciences LLC1$38
Mylan Specialty L.p.2$34
IBSA Pharma Inc.2$33
Metuchen Pharmaceuticals2$30
Mannkind Corporation2$30
Fidia Pharma USA Inc.2$28
Lundbeck LLC1$26
Viatris Specialty LLC1$24
Genentech USA, Inc.1$22
Sunovion Pharmaceuticals Inc.1$21
Hologic Sales And Service, LLC1$21
Astellas Pharma US Inc1$20
Biohaven Pharmaceutical Holding Company Ltd.1$20
Coopersurgical, Inc.1$18
GRT US Holding, Inc.1$16
Cipher Pharmaceuticals US LLC1$16
Cranial Technologies, Inc1$16
Currax Pharmaceuticals LLC1$16
Sumitomo Pharma America, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,666 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$279,846
Medicare patients
405
Services billed
4,331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide104$161,820
EliquisApixaban71$89,651
FarxigaDapagliflozin Propanediol52$70,910
XareltoRivaroxaban49$61,028
JardianceEmpagliflozin33$54,334
Tresiba Flextouch U-200Insulin Degludec16$25,400
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$23,357
JanuviaSitagliptin Phosphate12$19,017
MyrbetriqMirabegron12$16,182
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$11,127
VascepaIcosapent Ethyl15$10,540
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$10,481
Icosapent Ethyl28$10,272
Rosuvastatin Calcium671$8,731
Telmisartan272$6,470

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$4,633$161,820104 claims
PfizerEliquis$1,522$89,65171 claims
AstraZenecaFarxiga$3,611$70,91052 claims
Johnson & JohnsonXarelto$472$61,02849 claims
Boehringer IngelheimJardiance$1,774$54,33433 claims
GSKTrelegy Ellipta, Anoro Ellipta$585$34,48446 claims
MerckJanuvia, Steglatro$1,012$23,51123 claims
Astellas Pharma US IncMyrbetriq$20$16,18212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Libertyville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →